Longevity (LTY) ICO التصنيف والتفاصيل

Sale

٠١‏/٠٦‏/٢٠١٨

٣١‏/٠٧‏/٢٠١٨

100% منجز

الأموال المجمعة - لا توجد بيانات

past

Pre-sale

٢٨‏/٠٣‏/٢٠١٨

٠١‏/٠٦‏/٢٠١٨

100% منجز

الأموال المجمعة - لا توجد بيانات

past

تفاصيل الرمز

مبرقة كاتبة

LTY

تفاصيل الشركة

البلد المسجل

United Kingdom

حول Longevity

تقوم Longevity United ببناء سوق ذات خلفية متسلسلة ستستضيف البيانات التي تم الحصول عليها من المؤسسات الطبية ومراكز البحوث وخبراء طول العمر. يتم دمج هذه البيانات مع بيانات المستخدم من خلال التكامل مع تطبيق Eterly للجوال للواجهة الأمامية ، مما يتيح للتطبيق إنتاج خطط صحية مخصصة وتقديم توصيات للمستخدمين حول كيفية عيش حياة صحية ممكنة. سيستخدم النظام أيضًا أحدث الأبحاث الطبية حول المكملات الغذائية المتاحة وعقاقير العلاج التي تعود بالنفع على المستخدم. سيستخدم Longevity United استراتيجيات تشفير اقتصادية جديدة وتقنيات رمزية ؛ سيتم إصدار الرموز الطويلة العمر للمستخدمين كمكافأة لاستكمال خطط الصحة واللياقة بنجاح ، لرعاية عمل العلماء والباحثين ، ولجلب الاستثمار إلى المنصة من كبار مستثمري الرعاية الصحية والتطبيقات المحمولة والشركاء الاستراتيجيين. سيتمكن المستخدمون من & ldquo؛ الإنفاق & rdquo؛ رموز طول العمر الخاصة بهم على الخدمات المتميزة التي يتم تقديمها في سوق Longevity United.

٪ name٪ خريطة الطريق

March 2018

Token Pre-Sale – Blockchain platform development begins, Start of Token Pre-Sale Campaign. Supervision of Token Sale (also employing outside help); ensuring all elements of business plan and execution of token sale are compliant and transparent.Appoint CMO to lead marketing division; concerted PR campaign to take place throughout Token Sale; marketing documentation circulated widely; social media channels established; appointment of community manager to handle Token Sale.

April - June 2018

Identify and approach influencers within longevity industry and open dialogue who wish to learn more about Longevity United and become involved with project; approach partners and initiate discussions to establish best fit of research partner to platform; discuss awarding of tokens to facilitate providing research direct to platform. Marketing material circulation now turns to the Token Sale; multiple PR and media releases throughout campaign; round the clock monitoring of social media channels to ensure rapid response to questions and launch of media bounty scheme.Follow up sessions with selected partners; token award negotiations continue; first partnerships announced. Research channels firmly established between Longevity United and its research partners; Global legal review of all business to be conducted evaluating needs of each department and legal implications of launching Longevity United globally. Further hires made. Initial testing stage and advanced discussions with potential partners.

June - October 2018

Marketing continues to promote the several arms of Longevity United globally; offices established on several different countries across different continents.Data now stored within Longevity United platform with users able to access data, curated and refined by Al and independent experts for their health improvement. Investigations into all aspects of LU’s relationship with global pharma industry, data sharing with third parties, platform sales, blockchain security, data protection, medical treatment programmes, medical advice. Draft agreements in place for formalising relationships with hospitals & private health clinics; global review complete and action areas addressed - complete clarity concerning all legal implications of running a platform such as longevity United and App such as Eterly.

November 2018 - November 2019

Global legal review of all business to be conducted evaluating needs of each department and legal implications of launching Longevity United globally. Further hires made. Investigations into all aspects of Longevity United relationship with global pharma industry, data sharing with third parties, platform sales, blockchain security, data protection, medical treatment programmes, medical advice. Expansion of in-platform research conducted and of products and services offered through marketplace; global partnerships with scientific institutions, pharma and biomedical companies established.